Funding Round
Myomo raises $22M Series C to fund international expansion of MyoPro powered orthosis
MedTech Funding News4/9/2026·04/09/26🌐 USA
Summary
Cambridge-based Myomo secured $22M Series C led by Braemar Energy Ventures, with MedTech Venture Partners, to fund international expansion of the MyoPro EMG-controlled powered arm orthosis. CE mark obtained in Q2 2024 enables direct sales in Europe. The round also supports a new indication study for cervical SCI patients with incomplete motor function.
Why it matters
MyoPro's Medicare coverage established a US reimbursement pathway that international health systems can reference for coverage decisions. CE mark combined with proven US commercial traction makes Myomo a rare MedTech company with both regulatory and commercial proof points for international expansion.
#EMG#Industry#Neuroprosthetics#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in